Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics o | PGPM @DovePress https://t.co/utNanZ1Q8L
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke https://t.co/lWOhZpBHvJ
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke. - PubMed - NCBI https://t.co/D2rSWxHGFn
RT @PharmacyPodcast: Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation…
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke https://t.co/XbL7WdbTZi https://t.co/xWQBw8mURa
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with #af and acute #stroke | Read the study: https://t.co/U5jxV66JVv